CARB-X Funding Rounds (Antimicrobial Resistance)
CARB-X · Nonprofit
Source: CARB-X (curated) · View original posting ↗
Runs recurring annual themed funding rounds (typically a spring expression-of-interest window); themes and the next call are posted on carb-x.org/apply.
- AwardWhat a single award can be worth — the funder's published per-award amount or floor–ceiling range.
- Amount not listed
- DeadlineFinal application due date.
- Not yet posted
- Letter of intentDue date for the letter of intent (a short pre-application some funders require or request before the full proposal).
- —
- MechanismNIH activity code — the grant type (R01 research project, R21 exploratory, K series career development, F series fellowship, …).
- —
- DurationMaximum project period for a single award.
- —
- Expected awardsHow many awards the funder anticipates making under this opportunity.
- —
- Funding cycleHow often the program accepts applications (annual, multiple cycles per year, rolling, or one-time).
- Recurring (annual)
- Open dateWhen applications open (or opened).
- —
- Total fundingThe overall pool the funder expects to commit across ALL awards under this opportunity — not what one project receives.
- —
- Clinical trialWhether proposed projects must, may, or must not include a clinical trial.
- Optional / allowed
Research areas
Auto-classified from the title and description (keyword-based) — may be imperfect.
Description
Non-dilutive, milestone-based funding plus scientific and regulatory support to accelerate early-stage antibacterial/AMR products — therapeutics, vaccines, diagnostics — from hit-to-lead through first-in-human; academic centers and small companies are eligible, projects must target a priority pathogen, and developer cost-share is required. Curated entry; verify current terms at the program page.
This funder has no public API, so the entry is manually curated — confirm current amounts, deadlines, and eligibility on the source page.